Antibiotic-resistance plasmids encode Evangelion, a widespread mobile antiphage defence system
This study identifies Evangelion, a widespread mobile anti-phage defense system encoded on antibiotic-resistance plasmids in MRSA, which utilizes NAD⁺ depletion to trigger abortive infection against lytic phages, thereby linking plasmid-mediated antibiotic resistance with bacterial immunity.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Bacteria are constantly at war. They face threats from antibiotics, the medicines humans use to kill them, and from viruses called bacteriophages, which are nature's own predators that hunt and destroy bacterial cells. For decades, scientists have studied how bacteria fight back. They have discovered that bacteria possess a complex immune system, using various tools to detect and neutralize these viral invaders. At the same time, bacteria have become masters of sharing genetic material. They carry small, circular pieces of DNA called plasmids, which act like portable hard drives. These plasmids often carry instructions for resisting antibiotics, allowing bacteria to survive medical treatments. A major question in modern microbiology has been whether these same mobile genetic packages, which spread antibiotic resistance, also carry the tools for fighting viruses. If they do, it would mean that a single piece of DNA could simultaneously make a bacterium harder to kill with medicine and harder to kill with a virus, fundamentally changing how we understand bacterial survival and the spread of resistance.
A team of researchers set out to answer this question by looking at a specific type of dangerous bacteria known as methicillin-resistant Staphylococcus aureus, or MRSA. This bacterium is notorious for causing infections that are difficult to treat. The scientists focused on a naturally occurring plasmid found in a strain of MRSA called Mw2. They suspected this plasmid might hold a secret weapon against viruses. To test this, they removed the plasmid from the bacteria and then exposed the plasmid-free bacteria to a variety of bacteriophages. The result was immediate and clear: without the plasmid, the bacteria became highly vulnerable to infection. The plasmid was acting as a shield. By carefully examining the genetic code of the plasmid, the researchers identified a single gene responsible for this protection. They named this new defense system "Evangelion."
The discovery of Evangelion revealed a surprising connection between two major threats to human health. The gene that provides immunity against viruses is located on the same plasmid that carries genes for resisting antibiotics. In fact, when the researchers searched through a vast database of bacterial plasmids from around the world, they found that Evangelion-like systems are widespread. They appeared on hundreds of plasmids, many of which were already known to carry multiple antibiotic-resistance genes. This suggests that the ability to fight off viruses is not a rare accident but a common feature of the very genetic elements that drive the spread of drug-resistant bacteria. The researchers found that these defense systems are present in about 6.4 percent of the plasmids found in Staphylococcus species, indicating that a significant portion of these mobile genetic elements are equipped with both antibiotic resistance and viral immunity.
The scientists then worked to understand how Evangelion actually works. They found that the system is built from two main parts. One part is a conserved core, a structural foundation that is similar across different versions of the system found in various bacteria. The other part is a variable region that changes from one version to another. This variable region acts like a specialized sensor, allowing different versions of Evangelion to recognize and respond to different types of viruses. The researchers discovered that the system is triggered when a virus begins to replicate inside the bacterial cell. Specifically, the defense mechanism appears to detect the molecular machinery the virus uses to copy its own genetic material. Once activated, the system unleashes a destructive response. It depletes a vital molecule inside the cell called NAD+, which is essential for the cell's energy and survival. This causes the infected cell to die prematurely, a process known as abortive infection. By sacrificing itself, the infected cell prevents the virus from multiplying and spreading to neighboring bacteria, effectively saving the rest of the bacterial population.
The study also explored how bacteria might try to escape this defense. The researchers allowed viruses to evolve in the presence of the Evangelion system and observed which changes allowed them to succeed. The viruses that managed to break through the defense did not change their outer shell or their ability to enter the cell. Instead, they mutated the genes responsible for their internal replication machinery. This confirmed that Evangelion specifically targets the viral replication process. Furthermore, the researchers found that different versions of Evangelion protect against different groups of viruses. While the original version found in MRSA defends against a specific family of viruses called Silviaviruses, other versions found in different bacteria protect against entirely different viral families. This diversity suggests that the system has evolved to adapt to the specific viral threats present in different environments.
The implications of these findings extend beyond basic science. The research shows that the plasmids spreading antibiotic resistance are also shaping how bacteria interact with viruses. This means that the success of a plasmid in a bacterial population might depend not just on its ability to resist drugs, but also on its ability to protect its host from viral attacks. Conversely, the presence of these defense systems could alter the effectiveness of treatments that use viruses to kill bacteria, a strategy known as phage therapy. If a bacterium acquires a plasmid carrying Evangelion, it could suddenly become resistant to a virus that was previously thought to be a viable treatment option. The study highlights that the genetic landscape of bacteria is a complex web where resistance to medicine and immunity to viruses are often linked on the same mobile genetic elements. Understanding these connections is crucial for predicting how bacteria will evolve and for developing more effective strategies to combat infections in the future. The discovery of Evangelion adds a new layer to our understanding of bacterial survival, revealing that the tools for resisting antibiotics and the tools for fighting viruses are often packaged together, moving through bacterial populations as a single, powerful unit.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.